VCEL
Price
$34.05
Change
+$0.38 (+1.13%)
Updated
Sep 5 closing price
Capitalization
1.72B
61 days until earnings call
VNDA
Price
$4.61
Change
-$0.03 (-0.65%)
Updated
Sep 5 closing price
Capitalization
272.4M
53 days until earnings call
Interact to see
Advertisement

VCEL vs VNDA

Header iconVCEL vs VNDA Comparison
Open Charts VCEL vs VNDABanner chart's image
Vericel
Price$34.05
Change+$0.38 (+1.13%)
Volume$653.08K
Capitalization1.72B
Vanda Pharmaceuticals
Price$4.61
Change-$0.03 (-0.65%)
Volume$334.74K
Capitalization272.4M
VCEL vs VNDA Comparison Chart in %
Loading...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VCEL vs. VNDA commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCEL is a Hold and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (VCEL: $34.05 vs. VNDA: $4.61)
Brand notoriety: VCEL and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VCEL: 110% vs. VNDA: 68%
Market capitalization -- VCEL: $1.72B vs. VNDA: $272.4M
VCEL [@Biotechnology] is valued at $1.72B. VNDA’s [@Biotechnology] market capitalization is $272.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VCEL’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • VCEL’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VCEL’s TA Score shows that 3 TA indicator(s) are bullish while VNDA’s TA Score has 7 bullish TA indicator(s).

  • VCEL’s TA Score: 3 bullish, 4 bearish.
  • VNDA’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than VCEL.

Price Growth

VCEL (@Biotechnology) experienced а -6.35% price change this week, while VNDA (@Biotechnology) price change was -2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

VCEL is expected to report earnings on Nov 06, 2025.

VNDA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($1.72B) has a higher market cap than VNDA($272M). VCEL has higher P/E ratio than VNDA: VCEL (243.21) vs VNDA (137.00). VNDA YTD gains are higher at: -3.758 vs. VCEL (-37.989). VCEL has higher annual earnings (EBITDA): 16.2M vs. VNDA (-92.87M). VNDA has more cash in the bank: 326M vs. VCEL (117M). VNDA has less debt than VCEL: VNDA (11.6M) vs VCEL (99.8M). VCEL has higher revenues than VNDA: VCEL (249M) vs VNDA (203M).
VCELVNDAVCEL / VNDA
Capitalization1.72B272M632%
EBITDA16.2M-92.87M-17%
Gain YTD-37.989-3.7581,011%
P/E Ratio243.21137.00178%
Revenue249M203M123%
Total Cash117M326M36%
Total Debt99.8M11.6M860%
FUNDAMENTALS RATINGS
VCEL vs VNDA: Fundamental Ratings
VCEL
VNDA
OUTLOOK RATING
1..100
910
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
8995
PRICE GROWTH RATING
1..100
8655
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VNDA's Valuation (82) in the Biotechnology industry is in the same range as VCEL (89) in the Medical Specialties industry. This means that VNDA’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as VNDA (100) in the Biotechnology industry. This means that VCEL’s stock grew similarly to VNDA’s over the last 12 months.

VCEL's SMR Rating (89) in the Medical Specialties industry is in the same range as VNDA (95) in the Biotechnology industry. This means that VCEL’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's Price Growth Rating (55) in the Biotechnology industry is in the same range as VCEL (86) in the Medical Specialties industry. This means that VNDA’s stock grew similarly to VCEL’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for VCEL (100) in the Medical Specialties industry. This means that VNDA’s stock grew significantly faster than VCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VCELVNDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 2 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KBLB0.08N/A
+2.16%
Kraig Biocraft Laboratories, Inc.
UOVEY55.670.05
+0.09%
United Overseas Bank Ltd.
LNNGF2.38N/A
N/A
Li Ning Co., Ltd.
OERLF3.73N/A
N/A
OC Oerlikon Corp.
MDXXF0.08-0.02
-19.62%
PharmAla Biotech Holdings Inc.

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with DNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+1.13%
DNA - VCEL
36%
Loosely correlated
-4.54%
FTRE - VCEL
35%
Loosely correlated
+10.66%
CDXS - VCEL
34%
Loosely correlated
N/A
PLRX - VCEL
34%
Loosely correlated
+14.11%
KYTX - VCEL
33%
Loosely correlated
+8.54%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with OCUL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-0.65%
OCUL - VNDA
40%
Loosely correlated
+7.09%
IDYA - VNDA
38%
Loosely correlated
+5.15%
ZYME - VNDA
38%
Loosely correlated
+6.89%
AVIR - VNDA
38%
Loosely correlated
+1.20%
CGEM - VNDA
38%
Loosely correlated
+1.16%
More